Apollo Ingredients FY26 Income ₹5.03 Cr, Profit ₹0.71 Cr; Rights Issue Completes

SEBIEXCHANGE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Apollo Ingredients FY26 Income ₹5.03 Cr, Profit ₹0.71 Cr; Rights Issue Completes
Overview

Apollo Ingredients reported strong revenue and profit growth for FY 2025-26, with total income at ₹5.03 crore and net profit at ₹0.71 crore. A rights issue boosted its capital base, but EPS declined due to more shares.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Apollo Ingredients Ltd. Posts Strong FY26 Growth Amidst Compliance Challenges

Apollo Ingredients Ltd. reported a significant jump in total income to ₹5.03 crore for FY 2025-26, up from ₹3.08 crore in the previous year. Net profit soared to ₹0.71 crore, a substantial increase from ₹0.10 crore in FY 2024-25.

Reader Takeaway: Positive revenue and profit growth offset by regulatory and accounting compliance issues.

What just happened

Apollo Ingredients Ltd. announced its financial results for the fiscal year 2025-26, highlighting a substantial increase in both total income and net profit. The company's total income reached ₹5.03 crore, a rise from ₹3.08 crore in FY 2024-25. Net profit grew to ₹0.71 crore from ₹0.10 crore. The company also successfully completed a Rights Issue, strengthening its capital base.

Why this matters

This performance indicates robust operational growth for Apollo Ingredients. The successful capital infusion through the rights issue strengthens the company's financial position, potentially supporting its expansion plans. However, the declining Basic EPS to ₹0.68 from ₹2.44 is a key point for shareholders, attributed to the increased share count post-rights issue.

The backstory

Apollo Ingredients Ltd., formerly Indsoya Limited, is undergoing a strategic transformation. The company has been focusing on strengthening its capital structure. Its previous financial year (FY 2024-25) saw total income of ₹3.08 crore and a net profit of ₹0.10 crore.

What changes now

The company is set to diversify into new business areas, including the cultivation, processing, and trading of agricultural, horticultural, and food ingredients. It also aims to become an integrated healthcare solutions provider, venturing into healthcare institutions and diagnostic centers. These moves signal a significant shift in the company's strategic direction and business model.

Risks to watch

Investors should be aware of several compliance and operational concerns. The company faced fines from BSE for compliance issues and withdrew an appeal at SAT, paying ₹2.06 lakh. The statutory auditor noted the absence of an accounting software audit trail for FY 2025-26. Additionally, the company had only 2 permanent employees as of March 31, 2026, raising questions about execution capacity.

Peer comparison

(No verifiable peer comparison data available in the filing.)

Context metrics (time-bound)

  • FY 2025-26 Total Income: ₹5.03 crore
  • FY 2025-26 Net Profit: ₹0.71 crore
  • FY 2024-25 Total Income: ₹3.08 crore
  • FY 2024-25 Net Profit: ₹0.10 crore
  • Paid-up share capital increased from ₹0.20 crore to ₹5.20 crore post-Rights Issue.

What to track next

Shareholders should closely monitor the update of the company's name change on the BSE portal and its progress in rectifying accounting audit trail compliance. The Annual General Meeting on June 29, 2026, will be crucial for understanding management's strategy for diversification and addressing compliance gaps.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.